Dendritic cells in atherosclerotic inflammation: The complexity of functions and the peculiarities of pathophysiological effects

Frontiers in Physiology

Volumn 5 MAY, Issue , 2014, Pages

  Chistiakov, Dimitry A ^a   Sobenin, Igor A ^b,c,d   Orekhov, Alexander N ^b,c   Bobryshev, Yuri V ^b,e  

^a PIROGOV RUSSIAN NATIONAL RESEARCH MEDICAL UNIVERSITY   (Russian Federation)

^b Institute for Atherosclerosis Research   (Russian Federation)

^c INSTITUTE OF GENERAL PATHOLOGY AND PATHOPHYSIOLOGY   (Russian Federation)

^d INSTITUTE OF EXPERIMENTAL CARDIOLOGY   (Russian Federation)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Arteries; Atherogenesis; Atherosclerosis; Dendritic cells; Immune reactions; Inflammation

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GLYCOPROTEIN P 15095; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 3; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROGRAMMED DEATH 1 LIGAND 1; THYMUS AND ACTIVATION REGULATED CHEMOKINE;

ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ATHEROGENESIS; ATHEROSCLEROSIS; CELL ACTIVATION; CELL COUNT; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; DENDRITIC CELL; EFFECTOR CELL; HUMAN; IMMUNOTHERAPY; INFLAMMATION; MOLECULAR INTERACTION; NONHUMAN; PATHOPHYSIOLOGY; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE;

EID: 84904293220     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2014.00196     Document Type: Review

References (101)

1. Alberts-Grill, N., Denning, T. L., Rezvan, A., and Jo, H. (2013). The role of the vascular dendritic cell network in atherosclerosis. Am. J. Physiol. Cell. Physiol. 305, C1-C21. doi: 10.1152/ajpcell.00017.2013.
2. Ameli, S., Hultgårdh-Nilsson, A., Regnström, J., Calara, F., Yano, J., Cercek, B., et al. (1996). Effect of immunization with homologous LDL and oxidized LDL on early atherosclerosis in hypercholesterolemic rabbits. Arterioscler. Thromb. Vasc. Biol. 16, 1074-1079. doi: 10.1161/01.ATV.16.8.1074.
3. Benagiano, M., D'Elios, M. M., Amedei, A., Azzurri, A., van der Zee, R., Ciervo, A., et al. (2005). Human 60-kDa heat shock protein is a target autoantigen of T cells derived from atherosclerotic plaques. J. Immunol. 174, 6509-6517. doi: 10.4049/jimmunol.174.10.6509.
4. Bobryshev, Y. V. (2000). Dendritic cells and their involvement in atherosclerosis. Curr. Opin. Lipidol. 11, 511-517. doi: 10.1097/00041433-200010000-00009.
5. Bobryshev, Y. V. (2001). Can dendritic cells be exploited for therapeutic intervention in atherosclerosis? Atherosclerosis 154, 511-512. doi: 10.1016/S0021-9150(00)00692-4.
6. Bobryshev, Y. V. (2005). Dendritic cells in atherosclerosis: current status of the problem and clinical relevance. Eur. Heart J. 26, 1700-1704. doi: 10.1093/eurheartj/ehi282.
7. Bobryshev, Y. V. (2010). Dendritic cells and their role in atherogenesis. Lab. Invest. 90, 970-984. doi: 10.1038/labinvest.2010.94.
8. Bobryshev, Y. V., Babaev, V. R., Lord, R. S., and Watanabe, T. (1999). Ultrastructural identification of cells with dendritic cell appearance in atherosclerotic aorta of apolipoprotein E deficient mice. J. Submicrosc. Cytol. Pathol. 31, 527-531.
9. Bobryshev, Y. V., Cao, W., Phoon, M. C., Tran, D., Chow, V. T., Lord, R. S., et al. (2004). Detection of Chlamydophila pneumoniae in dendritic cells in atherosclerotic lesions. Atherosclerosis 173, 185-195. doi: 10.1016/j.atherosclerosis.2003.12.028.
10. Bobryshev, Y. V., and Lord, R. S. (1995a). Ultrastructural recognition of cells with dendritic cell morphology in human aortic intima. Contacting interactions of Vascular Dendritic Cells in athero-resistant and athero-prone areas of the normal aorta. Arch. Histol. Cytol. 58, 307-322. doi: 10.1679/aohc.58.307.
11. Bobryshev, Y. V., and Lord, R. S. (1995b). S-100 positive cells in human arterial intima and in atherosclerotic lesions. Cardiovasc. Res. 29, 689-696. doi: 10.1016/0008-6363(96)88642-1.
12. Bobryshev, Y. V., and Lord, R. S. (1998). Mapping of vascular dendritic cells in atherosclerotic arteries suggests their involvement in local immune-inflammatory reactions. Cardiovasc. Res. 37, 799-810. doi: 10.1016/S0008-6363(97)00229-0.
13. Bobryshev, Y. V., Moisenovich, M. M., Pustovalova, O. L., Agapov, I. I., and Orekhov, A. N. (2012). Widespread distribution of HLA-DR-expressing cells in macroscopically undiseased intima of the human aorta: a possible role in surveillance and maintenance of vascular homeostasis. Immunobiology 217, 558-568. doi: 10.1016/j.imbio.2011.03.014.
14. Bobryshev, Y. V., Taksir, T., Lord, R. S., and Freeman, M. W. (2001). Evidence that dendritic cells infiltrate atherosclerotic lesions in apolipoprotein E-deficient mice. Histol. Histopathol. 16, 801-808.
15. Bour-Jordan, H., Esensten, J. H., Martinez-Llordella, M., Penaranda, C., Stumpf, M., and Bluestone, J. A. (2011). Intrinsic and extrinsic control of peripheral T-cell tolerance by costimulatory molecules of the CD28/B7 family. Immunol. Rev. 241, 180-205. doi: 10.1111/j.1600-065X.2011.01011.x.
16. Busch, M., Westhofen, T. C., Koch, M., Lutz, M. B., and Zernecke, A. (2014). Dendritic cell subset distributions in the aorta in healthy and atherosclerotic mice. PLoS ONE 9:e88452. doi: 10.1371/journal.pone.0088452.
17. Butcher, M. J., and Galkina, E. V. (2012). Phenotypic and functional heterogeneity of macrophages and dendritic cell subsets in the healthy and atherosclerosis-prone aorta. Front. Physiol. 3:44. doi: 10.3389/fphys.2012.00044.
18. Caminschi, I., Maraskovsky, E., and Heath, W. R. (2012). Targeting dendritic cells in vivo for cancer therapy. Front. Immunol. 3:13. doi: 10.3389/fimmu.2012.00013.
19. Cartland, S. P., and Jessup, W. (2013). Dendritic cells in atherosclerosis. Curr. Pharm. Des. 19, 5883-5890. doi: 10.2174/1381612811319330007.
20. Cheong, C., and Choi, J. H. (2012). Dendritic cells and regulatory T cells in atherosclerosis. Mol. Cells 34, 341-347. doi: 10.1007/s10059-012-0128-9.
21. Chistiakov, D. A., Sobenin, I. A., and Orekhov, A. N. (2013). Regulatory T cells in atherosclerosis and strategies to induce the endogenous atheroprotective immune response. Immunol. Lett. 151, 10-22. doi: 10.1016/j.imlet.2013.01.014.
22. Choi, J. H., Cheong, C., Dandamudi, D. B., Park, C. G., Rodriguez, A., Mehandru, S., et al. (2011). Flt3 signaling-dependent dendritic cells protect against atherosclerosis. Immunity 35, 819-831. doi: 10.1016/j.immuni.2011.09.014.
23. Chyu, K. Y., Reyes, O. S., Zhao, X., Yano, J., Dimayuga, P., Nilsson, J., et al. (2004). Timing affects the efficacy of LDL immunization on atherosclerotic lesions in apo E (-/-) mice. Atherosclerosis 176, 27-35. doi: 10.1016/j.atherosclerosis.2004.04.016.
24. Chyu, K. Y., Zhao, X., Reyes, O. S., Babbidge, S. M., Dimayuga, P. C., Yano, J., et al. (2005). Immunization using an Apo B-100 related epitope reduces atherosclerosis and plaque inflammation in hypercholesterolemic apo E (-/-) mice. Biochem. Biophys. Res. Commun. 338, 1982-1989. doi: 10.1016/j.bbrc.2005.10.141.
25. Cocks, B. G., Chang, C. C., Carballido, J. M., Yssel, H., de Vries, J. E., and Aversa, G. (1995). A novel receptor involved in T-cell activation. Nature 376, 260-263. doi: 10.1038/376260a0.
26. Cybulsky, M. I., and Jongstra-Bilen, J. (2010). Resident intimal dendritic cells and the initiation of atherosclerosis. Curr. Opin. Lipidol. 21, 397-403. doi: 10.1097/MOL.0b013e32833ded96.
27. Daissormont, I. T., Christ, A., Temmerman, L., Sampedro Millares, S., Seijkens, T., Manca, M., et al. (2011). Plasmacytoid dendritic cells protect against atherosclerosis by tuning T-cell proliferation and activity. Circ. Res. 109, 1387-1395. doi: 10.1161/CIRCRESAHA.111.256529.
28. de Jager, S. C., and Kuiper, J. (2011). Vaccination strategies in atherosclerosis. Thromb. Haemost. 106, 796-803. doi: 10.1160/TH11-05-0369.
29. Dopheide, J. F., Obst, V., Doppler, C., Radmacher, M. C., Scheer, M., Radsak, M. P., et al. (2012). Phenotypic characterisation of pro-inflammatory monocytes and dendritic cells in peripheral arterial disease. Thromb. Haemost. 108, 1198-1207. doi: 10.1160/TH12-05-0327.
30. Döring, Y., Manthey, H. D., Drechsler, M., Lievens, D., Megens, R. T., Soehnlein, O., et al. (2012). Auto-antigenic protein-DNA complexes stimulate plasmacytoid dendritic cells to promote atherosclerosis. Circulation 125, 1673-1683. doi: 10.1161/CIRCULATIONAHA.111.046755.
31. Döring, Y., and Zernecke, A. (2012). Plasmacytoid dendritic cells in atherosclerosis. Front. Physiol. 3:230. doi: 10.3389/fphys.2012.00230.
32. Erbel, C., Sato, K., Meyer, F. B., Kopecky, S. L., Frye, R. L., Goronzy, J. J., et al. (2007). Functional profile of activated dendritic cells in unstable atherosclerotic plaque. Basic Res. Cardiol. 102, 123-132. doi: 10.1007/s00395-006-0636-x.
33. Fallarino, F., Grohmann, U., Hwang, K. W., Orabona, C., Vacca, C., Bianchi, R., et al. (2003). Modulation of tryptophan catabolism by regulatory T cells. Nat. Immunol. 4, 1206-1212. doi: 10.1038/ni1003.
34. Feig, J. E., and Feig, J. L. (2012). Macrophages, dendritic cells, and regression of atherosclerosis. Front. Physiol. 3:286. doi: 10.3389/fphys.2012.00286.
35. Fredrikson, G. N., Björkbacka, H., Söderberg, I., Ljungcrantz, I., and Nilsson, J. (2008). Treatment with apo B peptide vaccines inhibits atherosclerosis in human apo B-100 transgenic mice without inducing an increase in peptide-specific antibodies. J. Intern. Med. 264, 563-570. doi: 10.1111/j.1365-2796.2008.01995.x.
36. Fredrikson, G. N., Söderberg, I., Lindholm, M., Dimayuga, P., Chyu, K. Y., Shah, P. K., et al. (2003). Inhibition of atherosclerosis in apoE-null mice by immunization with apoB-100 peptide sequences. Arterioscler. Thromb. Vasc. Biol. 23, 879-884. doi: 10.1161/01.ATV.0000067937.93716.DB.
37. Freigang, S., Hörkkö, S., Miller, E., Witztum, J. L., and Palinski, W. (1998). Immunization of LDL receptor-deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes. Arterioscler. Thromb. Vasc. Biol. 18, 1972-1982. doi: 10.1161/01.ATV.18.12.1972.
38. Gao, J. F., McIntyre, M. S., Juvet, S. C., Diao, J., Li, X., Vanama, R. B., et al. (2011). Regulation of antigen-expressing dendritic cells by double negative regulatory T cells. Eur. J. Immunol. 41, 2699-2708. doi: 10.1002/eji.201141428.
39. Ge, J., Yan, H., Li, S., Nie, W., Dong, K., Zhang, L., et al. (2011). Changes in proteomics profile during maturation of marrow-derived dendritic cells treated with oxidized low-density lipoprotein. Proteomics 11, 1893-1902. doi: 10.1002/pmic.201000658.
40. George, J., Afek, A., Gilburd, B., Levkovitz, H., Shaish, A., Goldberg, I., et al. (1998). Hyperimmunization of apo-E-deficient mice with homologous malondialdehyde low-density lipoprotein suppresses early atherogenesis. Atherosclerosis 138, 147-152. doi: 10.1016/S0021-9150(98)00015-X.
41. Gotsman, I., Sharpe, A. H., and Lichtman, A. H. (2008). T-cell costimulation and coinhibition in atherosclerosis. Circ. Res. 103, 1220-1231. doi: 10.1161/CIRCRESAHA.108.182428.
42. Grassia, G., Macritchie, N., Platt, A. M., Brewer, J. M., Garside, P., and Maffia, P. (2013). Plasmacytoid dendritic cells: Biomarkers or potential therapeutic targets in atherosclerosis? Pharmacol. Ther. 137, 172-182. doi: 10.1016/j.pharmthera.2012.10.001.
43. Gu, P., Gao, J. F., D'Souza, C. A., Kowalczyk, A., Chou, K. Y., and Zhang, L. (2012). Trogocytosis of CD80 and CD86 by induced regulatory T cells. Cell. Mol. Immunol. 9, 136-146. doi: 10.1038/cmi.2011.62.
44. Habets, K. L., van Puijvelde, G. H., van Duivenvoorde, L. M., van Wanrooij, E. J., de Vos, P., Tervaert, J. W., et al. (2010). Vaccination using oxidized low-density lipoprotein-pulsed dendritic cells reduces atherosclerosis in LDL receptor-deficient mice. Cardiovasc. Res. 85, 622-630. doi: 10.1093/cvr/cvp338.
45. Hamburg, M. A., and Collins, F. S. (2010). The path to personalized medicine. N. Engl. J. Med. 363, 301-304. doi: 10.1056/NEJMp1006304.
46. Hansson, G. K., and Hermansson, A. (2011). The immune system in atherosclerosis. Nat. Immunol. 12, 204-212. doi: 10.1038/ni.2001.
47. Hermansson, A., Johansson, D. K., Ketelhuth, D. F., Andersson, J., Zhou, X., and Hansson, G. K. (2011). Immunotherapy with tolerogenic apolipoprotein B-100-loaded dendritic cells attenuates atherosclerosis in hypercholesterolemic mice. Circulation 123, 1083-1091. doi: 10.1161/CIRCULATIONAHA.110.973222.
48. Hjerpe, C., Johansson, D., Hermansson, A., Hansson, G. K., and Zhou, X. (2010). Dendritic cells pulsed with malondialdehyde modified low density lipoprotein aggravate atherosclerosis in Apoe(-/-) mice. Atherosclerosis 209, 436-441. doi: 10.1016/j.atherosclerosis.2009.10.003.
49. Iellem, A., Mariani, M., Lang, R., Recalde, H., Panina-Bordignon, P., Sinigaglia, F., et al. (2001). Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells. J. Exp. Med. 194, 847-853. doi: 10.1084/jem.194.6.847.
50. Jongstra-Bilen, J., Haidari, M., Zhu, S. N., Chen, M., Guha, D., and Cybulsky, M. I. (2006). Low-grade chronic inflammation in regions of the normal mouse arterial intima predisposed to atherosclerosis. J. Exp. Med. 203, 2073-2083. doi: 10.1084/jem.20060245.
51. Klingenberg, R., Lebens, M., Hermansson, A., Fredrikson, G. N., Strodthoff, D., Rudling, M., et al. (2010). Intranasal immunization with an apolipoprotein B-100 fusion protein induces antigen-specific regulatory T cells and reduces atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 30, 946-952. doi: 10.1161/ATVBAHA.109.202671.
52. Koltsova, E. K., Hedrick, C. C., and Ley, K. (2013). Myeloid cells in atherosclerosis: a delicate balance of anti-inflammatory and proinflammatory mechanisms. Curr. Opin. Lipidol. 24, 371-380. doi: 10.1097/MOL.0b013e328363d298.
53. Koltsova, E. K., and Ley, K. (2011). How dendritic cells shape atherosclerosis. Trends Immunol. 32, 540-547. doi: 10.1016/j.it.2011.07.001.
54. Kubin, M., Kamoun, M., and Trinchieri, G. (1994). Interleukin 12 synergizes with B7/CD28 interaction in inducing efficient proliferation and cytokine production of human T cells. J. Exp. Med. 180, 211-222. doi: 10.1084/jem.180.1.211.
55. Kushwah, R., and Hu, J. (2011). Role of dendritic cells in the induction of regulatory T cells. Cell. Biosci. 1, 20. doi: 10.1186/2045-3701-1-20.
56. Lievens, D., Habets, K. L., Robertson, A. K., Laouar, Y., Winkels, H., Rademakers, T., et al. (2013). Abrogated transforming growth factor beta receptor II (TGFβ RII) signalling in dendritic cells promotes immune reactivity of T cells resulting in enhanced atherosclerosis. Eur. Heart. J. 34, 3717-3727. doi: 10.1093/eurheartj/ehs106.
57. Ludewig, B., Freigang, S., Jäggi, M., Kurrer, M. O., Pei, Y. C., Vlk, L., et al. (2000). Linking immune-mediated arterial inflammation and cholesterol-induced atherosclerosis in a transgenic mouse model. Proc. Natl. Acad. Sci. U.S.A. 97, 12752-12757. doi: 10.1073/pnas.220427097.
58. Macritchie, N., Grassia, G., Sabir, S. R., Maddaluno, M., Welsh, P., Sattar, N., et al. (2012). Plasmacytoid dendritic cells play a key role in promoting atherosclerosis in apolipoprotein e-deficient mice. Arterioscler. Thromb. Vasc. Biol. 32, 2569-2579. doi: 10.1161/ATVBAHA.112.251314.
59. Maldonado, R. A., and von Andrian, U. H. (2010). How tolerogenic dendritic cells induce regulatory T cells. Adv. Immunol. 108, 111-165. doi: 10.1016/B978-0-12-380995-7.00004-5.
60. Mandal, K., Jahangiri, M., and Xu, Q. (2005). Autoimmune mechanisms of atherosclerosis. Handb. Exp. Pharmacol. 170, 723-743. doi: 10.1007/3-540-27661-0_27.
61. Manthey, H. D., and Zernecke, A. (2011). Dendritic cells in atherosclerosis: functions in immune regulation and beyond. Thromb. Haemost. 106, 772-778. doi: 10.1160/TH11-05-0296.
62. Millonig, G., Niederegger, H., Rabl, W., Hochleitner, B. W., Hoefer, D., Romani, N., et al. (2001). Network of vascular-associated dendritic cells in intima of healthy young individuals. Arterioscler. Thromb. Vasc. Biol. 21, 503-508. doi: 10.1161/01.ATV.21.4.503.
63. Nickel, T., Pfeiler, S., Summo, C., Kopp, R., Meimarakis, G., Sicic, Z., et al. (2012). oxLDL downregulates the dendritic cell homing factors CCR7 and CCL21. Mediators Inflamm. 2012:320953. doi: 10.1155/2012/320953.
64. Niessner, A., Sato, K., Chaikof, E. L., Colmegna, I., Goronzy, J. J., and Weyand, C. M. (2006). Pathogen-sensing plasmacytoid dendritic cells stimulate cytotoxic T-cell function in the atherosclerotic plaque through interferon-alpha. Circulation 114, 2482-2489. doi: 10.1161/CIRCULATIONAHA.106.642801.
65. Niessner, A., and Weyand, C. M. (2010). Dendritic cells in atherosclerotic disease. Clin. Immunol. 134, 25-32. doi: 10.1016/j.clim.2009.05.006.
66. Nilsson, J., Nordin Fredrikson, G., Schiopu, A., Shah, P. K., Jansson, B., and Carlsson, R. (2007). Oxidized LDL antibodies in treatment and risk assessment of atherosclerosis and associated cardiovascular disease. Curr. Pharm. Des. 13, 1021-1030. doi: 10.2174/138161207780487557.
67. Oderup, C., Cederbom, L., Makowska, A., Cilio, C. M., and Ivars, F. (2006). Cytotoxic T lymphocyte antigen-4-dependent down-modulation of costimulatory molecules on dendritic cells in CD4+ CD25+ regulatory T-cell-mediated suppression. Immunology 118, 240-249. doi: 10.1111/j.1365-2567.2006.02362.x.
68. Onishi, Y., Fehervari, Z., Yamaguchi, T., and Sakaguchi, S. (2008). Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation. Proc. Natl. Acad. Sci. U.S.A. 105, 10113-10118. doi: 10.1073/pnas.0711106105.
69. Onodera, T., Jang, M. H., Guo, Z., Yamasaki, M., Hirata, T., Bai, Z., et al. (2009). Constitutive expression of IDO by dendritic cells of mesenteric lymph nodes: functional involvement of the CTLA-4/B7 and CCL22/CCR4 interactions. J. Immunol. 183, 5608-5614. doi: 10.4049/jimmunol.0804116.
70. Palinski, W., Miller, E., and Witztum, J. L. (1995). Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis. Proc. Natl. Acad. Sci. U.S.A. 92, 821-825. doi: 10.1073/pnas.92.3.821.
71. Palucka, K., and Banchereau, J. (2012). Cancer immunotherapy via dendritic cells. Nat. Rev. Cancer 12, 265-277. doi: 10.1038/nrc3258.
72. Paulson, K. E., Zhu, S. N., Chen, M., Nurmohamed, S., Jongstra-Bilen, J., and Cybulsky, M. I. (2010). Resident intimal dendritic cells accumulate lipid and contribute to the initiation of atherosclerosis. Circ. Res. 106, 383-390. doi: 10.1161/CIRCRESAHA.109.210781.
73. Peluso, I., Morabito, G., Urban, L., Ioannone, F., and Serafini, M. (2012). Oxidative stress in atherosclerosis development: the central role of LDL and oxidative burst. Endocr. Metab. Immune Disord. Drug. Targets 12, 351-360. doi: 10.2174/187153012803832602.
74. Perrin-Cocon, L., Coutant, F., Agaugué, S., Deforges, S., André, P., and Lotteau, V. (2001). Oxidized low-density lipoprotein promotes mature dendritic cell transition from differentiating monocyte. J. Immunol. 167, 3785-3791. doi: 10.4049/jimmunol.167.7.3785.
75. Perrin-Cocon, L., Diaz, O., André, P., and Lotteau, V. (2013). Modified lipoproteins provide lipids that modulate dendritic cell immune function. Biochimie 95, 103-108. doi: 10.1016/j.biochi.2012.08.006.
76. Pierides, C., Bermudez-Fajardo, A., Fredrikson, G. N., Nilsson, J., and Oviedo-Orta, E. (2013). Immune responses elicited by apoB-100-derived peptides in mice. Immunol. Res. 56, 96-108. doi: 10.1007/s12026-013-8383-1.
77. Randolph, G. J., Beaulieu, S., Lebecque, S., Steinman, R. M., and Muller, W. A. (1998). Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking. Science 282, 480-483. doi: 10.1126/science.282.5388.480.
78. Rogers, L., Burchat, S., Gage, J., Hasu, M., Thabet, M., Willcox, L., et al. (2008). Deficiency of invariant V alpha 14 natural killer T cells decreases atherosclerosis in LDL receptor null mice. Cardiovasc. Res. 78, 167-174. doi: 10.1093/cvr/cvn005.
79. Shortman, K., and Naik, S. H. (2007). Steady-state and inflammatory dendritic-cell development. Nat. Rev. Immunol. 7, 19-30. doi: 10.1038/nri1996.
80. Sorg, R. V., Kögler, G., and Wernet, P. (1999). Identification of cord blood dendritic cells as an immature CD11c-population. Blood 93, 2302-2307.
81. Steinman, R. M., and Banchereau, J. (2007). Taking dendritic cells into medicine. Nature 449, 419-426. doi: 10.1038/nature06175.
82. Steinman, R. M., and Cohn, Z. A. (1973). Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J. Exp. Med. 137, 1142-1162. doi: 10.1084/jem.137.5.1142.
83. Steinman, R. M., Hawiger, D., and Nussenzweig, M. C. (2003). Tolerogenic dendritic cells. Annu. Rev. Immunol. 21, 685-711. doi: 10.1146/annurev.immunol.21.120601.141040.
84. Stemme, S., Faber, B., Holm, J., Wiklund, O., Witztum, J. L., and Hansson, G. K. (1995). T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc. Natl. Acad. Sci. U.S.A. 92, 3893-3897. doi: 10.1073/pnas.92.9.3893.
85. Stephens, T. A., Nikoopour, E., Rider, B. J., Leon-Ponte, M., Chau, T. A., Mikolajczak, S., et al. (2008). Dendritic cell differentiation induced by a self-peptide derived from apolipoprotein E. J. Immunol. 181, 6859-6871. doi: 10.4049/jimmunol.181.10.6859.
86. Subramanian, M., and Tabas, I. (2014). Dendritic cells in atherosclerosis. Semin. Immunopathol. 36, 93-102. doi: 10.1007/s00281-013-0400-x.
87. Takeda, M., Yamashita, T., Sasaki, N., and Hirata, K. I. (2012). Dendritic cells in atherogenesis: possible novel targets for prevention of Atherosclerosis. J. Atheroscler. Thromb. 19, 953-961. doi: 10.5551/jat.14134.
88. Tuttolomondo, A., Di Raimondo, D., Pecoraro, R., Arnao, V., Pinto, A., and Licata, G. (2012). Atherosclerosis as an inflammatory disease. Curr. Pharm. Des. 18, 4266-4288. doi: 10.2174/138161212802481237.
89. Van Brussel, I., Lee, W. P., Rombouts, M., Nuyts, A. H., Heylen, M., De Winter, B. Y., et al. (2014). Tolerogenic dendritic cell vaccines to treat autoimmune diseases: can the unattainable dream turn into reality? Autoimmun. Rev. 13, 138-150. doi: 10.1016/j.autrev.2013.09.008.
90. Van Brussel, I., Schrijvers, D. M., Van Vré, E. A., and Bult, H. (2013). Potential use of dendritic cells for anti-atherosclerotic therapy. Curr. Pharm. Des. 19, 5873-5882. doi: 10.2174/1381612811319330006.
91. VanderLaan, P. A., Reardon, C. A., Sagiv, Y., Blachowicz, L., Lukens, J., Nissenbaum, M., et al. (2007). Characterization of the natural killer T-cell response in an adoptive transfer model of atherosclerosis. Am. J. Pathol. 170, 1100-1107. doi: 10.2353/ajpath.2007.060188.
92. van Es, T., van Puijvelde, G. H., Foks, A. C., Habets, K. L., Bot, I., Gilboa, E., et al. (2010). Vaccination against Foxp3(+) regulatory T cells aggravates atherosclerosis. Atherosclerosis 209, 74-80. doi: 10.1016/j.atherosclerosis.2009.08.041.
93. van Leeuwen, M., Damoiseaux, J., Duijvestijn, A., and Tervaert, J. W. (2009). The therapeutic potential of targeting B cells and anti-oxLDL antibodies in atherosclerosis. Autoimmun. Rev. 9, 53-57. doi: 10.1016/j.autrev.2009.03.001.
94. van Puijvelde, G. H., Hauer, A. D., de Vos, P., van den Heuvel, R., van Herwijnen, M. J., van der Zee, R., et al. (2006). Induction of oral tolerance to oxidized low-density lipoprotein ameliorates atherosclerosis. Circulation 114, 1968-1976. doi: 10.1161/CIRCULATIONAHA.106.615609.
95. Van Vré, E. A., Van Brussel, I., Bosmans, J. M., Vrints, C. J., and Bult, H. (2011). Dendritic cells in human atherosclerosis: from circulation to atherosclerotic plaques. Mediators Inflamm. 2011, 941396. doi: 10.1155/2011/941396.
96. Villadangos, J. A., and Young, L. (2008). Antigen-presentation properties of plasmacytoid dendritic cells. Immunity 29, 352-361. doi: 10.1016/j.immuni.2008.09.002.
97. Weber, C., Meiler, S., Döring, Y., Koch, M., Drechsler, M., Megens, R. T., et al. (2011). CCL17-expressing dendritic cells drive atherosclerosis by restraining regulatory T cell homeostasis in mice. J. Clin. Invest. 121, 2898-2910. doi: 10.1172/JCI44925.
98. Yamanaka, R., and Kajiwara, K. (2012). Dendritic cell vaccines. Adv. Exp. Med. Biol. 746, 187-200. doi: 10.1007/978-1-4614-3146-6_15.
99. Yilmaz, A., Lochno, M., Traeg, F., Cicha, I., Reiss, C., Stumpf, C., et al. (2004). Emergence of dendritic cells in rupture-prone regions of vulnerable carotid plaques. Atherosclerosis 176, 101-110. doi: 10.1016/j.atherosclerosis.2004.04.027.
100. Yilmaz, A., Weber, J., Cicha, I., Stumpf, C., Klein, M., Raithel, D., et al. (2006). Decrease in circulating myeloid dendritic cell precursors in coronary artery disease. J. Am. Coll. Cardiol. 48, 70-80. doi: 10.1016/j.jacc.2006.01.078.
101. Zhou, X., Robertson, A. K., Hjerpe, C., and Hansson, G. K. (2006). Adoptive transfer of CD4+ T cells reactive to modified low-density lipoprotein aggravates atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 26, 864-870. doi: 10.1161/01.ATV.0000206122.61591.ff.